Aktuell May 15, 2024 Allegria Therapeutics nimmt 3,5 Millionen Dollar in Seed-Runde ein Allegria Therapeutics hat eine Seed-Finanzierung von 3,5 Millionen Dollar durch den Gründungsinvestor Forty51 Ventures erhalten. Das Biotech-Star...
News May 15, 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
News May 03, 2024 Basel research paves way for new drugs Chemists at the University of Basel have developed a new synthesis approach to artificially create terpenes. These contain substances that can be...
News Feb 06, 2024 QUMEA secures investment of 9 million Swiss francs QUMEA has raised funding of 9 million Swiss francs as part of an oversubscribed Series A financing round. With this fresh capital, the digital he...
News Dec 18, 2023 Planzer and Galenica launch Health Supply AG Planzer and Galenica are founding the joint venture Health Supply AG in Villmergen in the canton of Aargau. The aim is to make the transport of m...
Success stories Apr 23, 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
Actualités Nov 02, 2023 Quatre start-ups genevoises innovantes reçoivent le soutien du FIF Le FIF a soutenu quatre start-ups prometteuses pour favoriser l’innovation dans le cadre des Objectifs de Développement Durable de l’ONU.
News Mar 26, 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News Nov 02, 2023 Four innovative Geneva start-ups receive FIF support Geneva's FIF has backed four promising start-ups, fostering innovation in line with the UN's Sustainable Development Goals.
News Mar 13, 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
Success stories Apr 04, 2024 Snake venum for the Spanish pharma industry Pentapharm, a science-based company located in the Basel area, is a leading international supplier of high-quality biochemical materials for vari...
News Mar 26, 2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...
News May 26, 2023 Researchers at Kantonsspital St.Gallen find new approach for brain tumors St.Gallen - An international team of scientists led by Kantonsspital St.Gallen have developed new research approaches to combat malignant brain t...
Success stories Jan 31, 2023 BÜCHI Labortechnik: Konsequente Go-to-Market-Strategie BÜCHI Labortechnik generiert 97% des Umsatzes im Ausland. Mit 20 Tochtergesellschaften und zahlreichen Vertriebspartnern auf allen Kontinenten ve...
News Mar 18, 2024 Neuria enters Vanguard Accelerator to gameify healthier lifestyles Neuria Digital Therapeutics has become the inaugural start-up of 2024 to be embraced by the Vanguard Accelerator program.
News Mar 01, 2024 Idorsia enters collaboration with Viatris The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the de...
Success stories Jan 31, 2023 BÜCHI Labortechnik: Consistent go-to-market strategy BÜCHI generates 97% of its turnover abroad. With 20 subsidiaries and numerous sales partners on all continents, the company is consistently pursu...
Success stories Jan 31, 2023 BÜCHI Labortechnik: strategia go-to-market coerente BÜCHI Labortechnik genera il 97% del suo fatturato all’estero e, con le sue 20 filiali e i suoi numerosi partner di vendita in tutti i ...